The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Risk factors for oral mucositis (OM) in multiple myeloma (MM) patients receiving high-dose melphalan (Mel) prior to autologous stem cell transplantation (SCT).
Bhavana Bhatnagar
No relevant relationships to disclose
Olga G. Goloubeva
No relevant relationships to disclose
Steven Gilmore
No relevant relationships to disclose
Arnold Hoffman
No relevant relationships to disclose
Kathleen Ruehle
No relevant relationships to disclose
Gorgun Akpek
No relevant relationships to disclose
Aaron Rapoport
No relevant relationships to disclose
Saul Yanovich
No relevant relationships to disclose
Ashraf Z. Badros
No relevant relationships to disclose